Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders and Growing Awareness among People to Drive the Demand

Region:Asia

Author(s):

Product Code:KR329

Download Sample Report download
Buy the Full ReportStarting from $1500
Published on

July 2015

Total pages

197

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $1500

About the Report

About the Report

The report titled 'Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders and Growing Awareness among People to Drive the Demand' provides a comprehensive analysis of cardiac pacemaker market in Asia. The report covers various aspects such as market size of cardiac pacemaker market, segmentation on the basis of therapeutic specification, implantability, number of chambers, and volume of exports and imports for cardiac pacemakers. The report is useful for pharmaceuticals companies, retail chains, consultants, healthcare professionals and new players venturing in the market. The market is dominated by few global players including Medtronic, Biotronik, Boston scientific and others.

Asia Pacific Region

The cardiac pacemaker market in Asia Pacific is driven by rising demand and investment level of government, registered revenues of USD ~ million in 2014. With the advent of new cardiac pacemaker manufacturers in the industry, the revenues increased by 11.8% compared to 2013 where the total revenues were USD ~ million. Each segment in the cardiac pacemaker market is subject to a gamut of different factors such as prevalence rate of cardiac disorders, price cuts and number of players in the market plays an important role in determining their respective revenues. The cardiac pacemaker market of Asia has grown at a CAGR of 12.4% from USD ~ million in’2009 to USD ~ million in 2014. In more developed markets of Asia-Pacific region, including countries such as Japan and China, the offerings from the market players are expected to be diverse, focused mainly on customized demands. Additionally, the market is predicted to witness expansion in terms of the new and innovative pacemakers because of rising cardiac related incidences and growing awareness. The Asia-Pacific cardiac pacemaker market is expected to grow at a CAGR of 15.2% from 2014-2019 on account of increasing affluence of consumers towards healthy lifestyles and treatment of cardiac disorders in the recent years.
The Asia cardiac pacemaker market is comprised of global manufacturers that specialize in designing, manufacturing of their products. Global market revenues of Medtronic from sale of anti-cancer drugs have increased noticeably to USD ~ million in 2014, making it the largest player in cardiac pacemaker space. Biotronik was the second largest player in 2014. An inclination in the death rates of cardiac patients due lack of proper treatment provides and a huge opportunity to pharmaceutical companies to deliver effective pacemaker products in the market and thus contributing to higher revenue of cardiac pacemaker market.
The market for Cardiac pacemaker in Asia-Pacific is changing at a rapid rate. Furthermore, new upcoming pacemakers, investment by government on Healthcare as well as competitive pressures have been significantly changing the market.

India

The cardiac pacemaker market in India, which is driven by the development of new and innovative cardiac pacemakers, involving move from pacemakers with VVIR to MRI Pacemakers has registered revenues of INR ~ million in 2014. With the entry of new cardiac pacemaker manufacturers in the industry, the revenues increased by ~% compared to 2013 where the total revenues was INR ~ million. A major factor that has contributed to such a stupendous growth of this market is advances in technologies. Owing to this advancement in technology, the cardiac health issues are diagnosed much frequently and thus better treatment can be provided to the patients. The cardiac pacemaker market of India has grown at a CAGR of ~% from INR ~ million in 2009 to INR ~ million in 2014. The main competitors’ in India oncology space include Boston scientific, Medtronic and Medived Innovations amongst others. The India Cardiac pacemaker market is expected to grow at a CAGR of 18.5% from 2014-2019 due to greater influx of patients in cardiac care centers which has originated from rising awareness among the people about the right place for best treatment and will continue to escalate the growth of cardiac treatment in India.

China

China has witnessed continuous and substantial rise in frequency of cardiac cases as well as deaths caused by cardiac disorders. This rapid rise has been attributed to factors such as changing lifestyles and dietary patterns, increasing consumption of tobacco, heavy smoking and several other proximate causes. The revenue of cardiac pacemaker market in China increased by 13.1% compared to 2013 where the total revenues was USD ~ million. The market has grown at a CAGR of 20.8% from USD ~million in 2009 to USD ~ million in 2014. The China cardiac pacemaker has been anticipated to incline at a CAGR of 20.9% to USD ~ million in 2019.

Japan

The cardiac pacemaker market in Japan in the future is envisaged to augment at a CAGR of 13.0% during 2014-2019. The revenues are expected to reach USD ~ million by 2019. Japan cardiac pacemaker market revenues have inclined at a CAGR of 8.7% from USD ~ million in 2009 to USD ~ million in 2014. The cardiac pacemaker market in Japan has been primarily dominated by the internal pacemakers, which has commanded a massive share of ~% in the overall revenues of the cardiac pacemaker market during 2014. Japan cardiac pacemaker market in the outlook period, is likely to augment at a positive CAGR of 13.0% during 2014-2019, owing to consistent surging growth of cardiac disorders and innovations by these major players, coupled with enhancement in production capacity as well as extension in the coverage areas, towards newer states and expanding to newer geographies.

South Korea

South Korea’s has highly fragmented cardiac pacemaker market, where major proportion of the market being covered by global pharmaceutical companies and very less in hands of local pharmaceutical companies. The sales of pacemaker were registered as USD ~ million in 2009 which grew at a CAGR of 24.6% to reach USD ~ million in 2014.

Key Topics Covered in the Report:

  • The market size of the cardiac pacemaker market in Asia
  • The market size of the internal and external pacemaker in Asia cardiac pacemaker market.
  • The market size of the local and global players in Asia cardiac pacemaker market.
  • The market size of the India cardiac pacemaker, China cardiac pacemaker, Japan cardiac pacemaker market and South Korea cardiac pacemaker market.
  • Market segmentation of the cardiac pacemaker on the basis of implantability, number of chambers and specifications
  • SWOT and Porter Five force Analysis of India, China and Japan cardiac pacemaker market.
  • Trends and Development in the Asia cardiac pacemaker market.
  • Government Regulations in the India and China cardiac pacemaker market.
  • Competitive landscape detailed company profiles and market share of the major manufacturers of cardiac pacemaker in Asia as well as India, China, Japan and others
  • Macro Economic factors affecting India, China and Japan cardiac pacemaker market.
  • Future outlook and projections of Asia cardiac pacemaker market on the basis of – geography.

Products

Products

Accolade Pacemaker, Essentio Pacing System, Adapta, MRI Sure Scan Pacemaker, Assurity Pacemaker, Stellar Pacemaker, External Pacemaker, Internal Pacem


Companies

Medtronic, Sorin Group, Biotronik, Boston Scientific Corporation, St Jude Medical, Medived Innovations Pvt Ltd, Qinming Pharmaceuticals Ltd, Fukuda Denshi, Japan Lifeline

Table of Contents

Table of Contents

1. Cardiac Pacemaker Market
1.1. Global Cardiac Pacemaker Market Introduction and Market Size, 2009-2014
1.2. Asia- Pacific Cardiac Pacemaker Market
1.2.1. Asia-Pacific Cardiac Pacemaker Market Introduction and Market Size, 2009-2014
2. India Cardiac Hospital Market
2.1. India Cardiology Specialty Hospitals Market Size, FY’2010-FY’2014
2.1.1. List of Major Cardiology Specialty Hospitals in India-State Presence and Number of Beds
2.2. India Cardiology Specialty Hospitals Market Segmentation
2.2.1. By States, FY’2014
2.2.2. By Surgical and Diagnostic Procedures, FY’2014
2.3. Revenue of Major Cardiology Specialty Hospitals in India, FY’2014
2.3.1. Competitive Landscape of Major Cardiology Hospitals in India
2.4. Cost of Key Cardiology Procedures in Cardiac Specialty Hospitals in India
3. India Cardiac Pacemaker Market
3.1. India Cardiac Pacemaker Market Introduction
3.2. India Cardiac Pacemaker Market Stake holders and Value Chain Analysis
3.3. India Cardiac Pacemaker Market Size by Revenue, FY’2009-FY’2014
3.4. India Cardiac Pacemaker Market Segmentation, FY’2014
3.4.1. By Implantability, FY’ 2014
3.4.2. By Number of Chambers, FY’ 2014
3.4.3. By Specification, FY’2014
3.5. India Cardiac Pacemaker Market Growth Drivers and Restraints
3.5.1. Growth Drivers
3.5.2. Growth Restraints
3.6. India Cardiac Pacemaker Market Analysis
3.6.1. SWOT Analysis
3.6.1.1. Strengths
3.6.1.2. Weaknesses
3.6.1.3. Opportunities
3.6.1.4. Threats
3.6.2. Porter Five Force Analysis
3.7. India Cardiac Pacemaker Market Trends and Developments
Improvement in Technology
Increasing Investment in Hospitals
Expansion of Specialty Centres in Rural Towns
3.8. India Cardiac Pacemaker Market Government Regulations
3.8.1. Licenses Required for Manufacture and Distribution of Medical Equipments
3.8.2. Clinical Trials
3.8.3. Product Standards
3.8.4. Revised Guidelines
3.9. India Cardiac Pacemaker Market Trade Scenario, FY’2009-FY’2014
3.9.1. India Cardiac Pacemaker Import by Demand and Value, FY’2009-FY’2014
3.9.2. India Cardiac Pacemaker Market Export by Demand and Value, FY’2009-FY’2014
3.10. India Cardiac Pacemaker Market Competitive Landscape
3.11. India Cardiac Pacemaker Market: Company Profiles
3.11.1. Boston Scientific Pvt Ltd
3.11.1.1. Business Overview
3.11.1.2. Business Strategies
3.11.1.3. Financial and Operating Performance, 2009-2014
3.11.1.4. Product Portfolio
3.11.2. Medtronic Pvt Ltd.
3.11.2.1. Business Overview
3.11.2.2. Business Strategies
3.11.2.3. Financial and Operating Performance, FY’2009-FY’2014
3.11.2.4. Product Portfolio
3.11.3. St Jude Medical
3.11.3.1. Business Overview
3.11.3.2. Business Strategies
3.11.3.3. Financial and Operating Performance, 2009-2014
3.11.3.4. Product Portfolio
3.11.4. MediVed Innovations Pvt Ltd.
3.11.4.1. Business Overview
3.11.4.2. Business Strategies
3.11.4.3. Product Portfolio
3.12. India Cardiac Pacemaker Market Future Outlook & Projections, FY’2015-FY’2019
3.12.1. India Cardiac Pacemaker Market Future Projections, FY’2015-FY’2019
3.13. Macro Economic Factors in India Cardiac Pacemaker Market
3.13.1. Population Level, 2009-2019
3.13.2. GDP, 2009-2019
3.13.3. Spending on Healthcare, 2009-2019
3.13.4. Personal Disposable Income, FY’2009-FY’2019
3.13.5. Number of Hospitals, 2009-2019
4. China Cardiac Pacemaker Market
4.1. China Cardiac Pacemaker Market Introduction
4.2. China Cardiac Pacemaker Market Distribution Chain
4.3. China Cardiac Pacemaker Market Size by Revenue, 2009-2014
4.4. China Cardiac Pacemaker Market Segmentation, 2014
4.4.1. By Implantability
4.4.2. By Number of Chambers
4.4.3. By Arial Sensitivity
4.5. China Cardiac Pacemaker Growth Drivers and Restraints
4.6. China Cardiac Pacemaker Market Analysis
4.6.1. SWOT Analysis
4.6.1.1. Strengths
4.6.1.2. Weaknesses
4.6.1.3. Opportunities
4.6.1.4. Threats
4.6.2. Porter Five Force Analysis
Measures to Overcome Porter’s Five Forces
4.7. China Cardiac Pacemaker Market Competitive Landscape
4.8. China Cardiac Pacemaker Market Future Outlook & Projections, 2015-2019
4.8.1. China Cardiac Pacemaker Market Future projections, 2015-2019
4.9. Macro Economic Factors Affecting China Cardiac Pacemaker Market
4.9.1. Total Population of China, 2009-2019
4.9.2. Gross Domestic Product, 2009-2019
4.9.3. Total Spending on Healthcare, 2009-2019
4.9.4. Number of Hospitals, 2009-2019
4.9.5. Out of Pocket Expenses on Healthcare, 2009-2019
5. Japan Cardiac Pacemaker Market
5.1. Japan Cardiac Pacemaker Market Introduction
5.2. Japan Cardiac Pacemaker Market Size by Revenue, 2009-2014
5.3. Japan Cardiac Pacemaker Market Segmentation, 2014
5.3.1. By Implantability
5.3.2. By Number of Chambers
5.3.3. By Specification
5.4. Japan Cardiac Pacemaker Growth Drivers and Restraints
5.4.1. Growth Drivers
5.5. Japan Cardiac Pacemaker Market Analysis
5.5.1. SWOT Analysis
5.5.2. Porter Five Force Analysis
Measure to Overcome Porter Five Forces
5.6. Japan Cardiac Pacemaker Market Trade Scenario, 2009-2014
5.6.1. Japan Cardiac Pacemaker Market Import, 2009-2014
5.6.2. Japan Cardiac Pacemaker Market Export, 2009-2014
5.7. Japan Cardiac Pacemaker Market Competitive Landscape
5.7.1. Domestic Players
5.7.2. Global Players
5.8. Japan Cardiac Pacemaker Market Future Outlook & Projections, 2015-2019
5.8.1. Japan Cardiac Pacemaker Market Future Projections, 2015-2019
5.9. Macro Economic factors in Japan Cardiac Pacemaker Market
5.9.1. Population of Japan above 65 years, 2009-2019
5.9.2. GDP at Current Prices, 2009-2019
5.9.3. Spending on Health care, 2009-2019
6. South Korea Cardiac Pacemaker Market Snapshot
6.1. South Korea Cardiac Pacemaker Market Introduction and Size, 2009-2014
6.2. South Korea Cardiac Pacemaker Market Regulatory System
6.3. South Korea Cardiac Pacemaker Market Growth Drivers and Restraints
6.4. South Korea Cardiac Pacemaker Market Analysis
6.4.1. SWOT Analysis
7. Asia-Pacific Cardiac Pacemaker Market Future Outlook and Projections, 2015-2019
7.1. Cause and Effect Relationship between Independent and Dependent Factors
7.2. Asia-Pacific Cardiac Pacemaker Market Future Outlook and Projections, 2015-2019
7.3. By Geography, 2015-2019
8. Analyst Recommendations
Introduction
Augmenting Variables in the Cardiac Pacemaker Market
Impacting Negative Variables in Cardiac Pacemaker Market
8.1. Opportunities
8.1.1. Effective Healthcare Deliver Models
8.1.2. Rising Ageing Population, 2009-2014
8.2. Pre-requisites
8.2.1. Expansion through Tie-Ups
9. Appendix
9.1. Market Definition
9.2. Abbreviations
9.3. Research Methodology
Data Collection Methods
Approach
Variables (Independent and Dependent)
Final Conclusion
9.4. Disclaimer


List of Figure

Figure 1: Global Cardiac Pacemaker Market Size on the Basis of Revenue in USD Million and Growth rate in Percentage (%), 2009-2014
Figure 2: Asia-Pacific Cardiac Pacemaker Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2009-2014
Figure 3: Asia Pacific Cardiac Pacemaker Market Revenue Segmentation on the Basis of Geography in Percentage (%), 2009-2014
Figure 4: India Cardiology Specialty Hospitals Market Size by Revenue in INR Million, FY’2010-FY’2014
Figure 5: India Cardiology Hospitals Market Segmentation by States in Percentage (%), FY’2014
Figure 6: India Cardiology Hospital Market Segmentation by Surgical and Diagnostic Procedures on the Basis of Revenue Contribution in Percentage (%), FY’2014
Figure 7: Factors for Rise in Cardiovascular Cases in India
Figure 8: Value Chain Analysis of India Pacemaker Market
Figure 9: India Pacemaker Market Distribution Channel
Figure 10: India Pacemaker Market Size on the Basis of Revenue in INR Million and Growth Rate in Percentage (%), FY’2009-FY’2014
Figure 11: India Cardiac Pacemaker Market- SWOT Analysis
Figure 12: Total Imports of Cardiac Pacemaker by India in INR Million, FY’2009-FY’2014
Figure 13: Imports of Cardiac Pacemaker by India from Major Destinations on the basis of Revenue in Percentage (%), FY’2014
Figure 14: Total Exports of Cardiac Pacemaker from India in INR Million, FY’2009-FY’2014
Figure 15: India Exports of Cardiac Pacemaker to Major Destinations in Percentage (%), FY’2014
Figure 16: SWOT Analysis of Boston Scientific Pvt Limited
Figure 17: Revenue of Boston Scientific from Sales of Pacemakers in USD Million, CY’2009-CY’2014
Figure 18: Medtronic Global Revenue from Sale of Pacemaker Systems in USD Million and Growth rate in Percentage (%), 2009-2014
Figure 19: Medtronic Asia-Pacific Revenue from Sale of Pacemaker Systems in USD Million and Growth rate in Percentage (%), 2009-2014
Figure 20: Global Segmentation of Total Cardiac Rhythm Management Sales of Medtronic in Percentage (%), 2009-2014
Figure 21: Global Segmentation of Total revenue of Medtronic on the Basis of Therapies in Percentage (%), 2014
Figure 22: St Jude Medical Key Milestones in Pacemaker Segment
Figure 23: St Jude Medical Sales of Pacemaker in USD Million and Growth Rate in Percentage (%), CY’2009-CY’2014
Figure 24: India Cardiac Pacemaker Market Future Projections by Revenue in INR Million, FY’2015-FY’2019
Figure 25: Total Population in India in Million, 2009-2019
Figure 26: India Population Demography by Age Structure in Percentage (%), 2014
Figure 27: Middle Class Population of India in Million, 2009 –2019
Figure 28: Upper Class Population of India in Million, 2009 –2019
Figure 29: GDP of India at Current Prices in INR Million, 2009-2019
Figure 30: Total Spending on Healthcare in India in INR Million, 2009-2019
Figure 31: Personal Disposable Income in India in INR Billion, FY’2009- FY’2019
Figure 32: Number of Private Hospitals in India, 2009-2019
Figure 33: Number of Government Hospitals in India, 2009-2019
Figure 34: China Cardiac Pacemaker Market-Value Distribution Chain
Figure 35: China Cardiac Pacemaker Market Size by Revenue in USD Million and Growth Rate in Percentage (%), 2009-2014
Figure 36: China Cardiac Pacemaker Market Attractiveness and Constraints
Figure 37: Porter’s Five Forces Analysis of China Cardiac Pacemaker Market
Figure 38: Market Share of Major Players in China Cardiac Pacemaker Market in Percentage (%), 2014
Figure 39: China Cardiac Pacemaker Market Future Projections on the Basis of Revenue in USD Million, 2015-2019
Figure 40: Total Population of China in Million, 2009-2019
Figure 41: Population of China (65 years and above) in Million, 2009-2019
Figure 42: Gross Domestic Product of China in USD Billion, 2009-2019
Figure 43: Total Spending on Health Care in China in USD Million, 2009-2019
Figure 44: Government Spending on Health Care in China in USD Million, 2009-2019
Figure 45: Number of Hospitals in China, 2009-2019
Figure 46: Out of Pocket Expenses on Healthcare in China in USD Billion, 2009-2019
Figure 47: Japan Cardiac Pacemaker Market Size by Revenue in USD Million and Growth in Percentage (%), 2009-2014
Figure 48: Effect of Porter’s Five Forces on Japan Cardiac Pacemaker Market
Figure 49: Japan’s Import of Cardiac Pacemaker by Value in USD Thousand and Growth Rate in Percentage (%), 2009-2014
Figure 50: Japan’s Export of Cardiac Pacemaker by Value in USD Thousand and Growth Rate in Percentage (%), 2009-2014
Figure 51: Japan’s Cardiac Pacemaker Market Future Projections on the Basis of Revenues in USD Million, 2015-2019
Figure 52: Population Ageing 65 years and above of Japan in Million, 2009-2019
Figure 53: Japan GDP at Current Prices in USD Million, 2009-2019
Figure 54: Total Spending on Health Care in Japan in USD Million, 2009-2019
Figure 55: South Korea Cardiac Pacemaker Market Size on the Basis of Revenue in USD Million, 2009-2014
Figure 56: Asia-Pacific Cardiac Pacemaker Market Future Projections on the Basis of Revenues in USD Million, 2015-2019
Figure 57: Asia Pacific cardiac Pacemaker Market Future Projections Segmentation on the Basis of Geography in Percentage (%), 2015-2019


List of Table

Table 1: Major 5 Causes of Deaths in India by Demography, Gender and Class of People in India
Table 2: List of Major Cardiology Hospitals in India by State Presence and Number of Beds
Table 3: Revenue of Major Cardiology Single Specialty Hospitals in India in INR Million, FY’2014
Table 4: Competitive Landscape of Major Cardiology Hospitals (Fortis Escorts Heart Institute, Narayana Health, Frontier Lifeline Hospital, Asian Heart Institute and Others) in India
Table 5: Narayana Health Single Specialty Cardiac Hospitals of Narayana Health Chain
Table 6: Average Cost of Key Procedures at Cardiology Hospital in India in INR
Table 7: Average Cost of Stent and Pacemaker to a Patient in INR
Table 8: India Cardiac Pacemaker Market Segmentation by Implantability in Percentage (%) and INR Million, FY’2014
Table 9: India Cardiac Pacemaker Market Segmentation by Number of Chambers in Percentage (%) and INR Million, 2014
Table 10: India Cardiac Pacemaker Market Segmentation by Specification in Percentage (%) and INR Million, 2014
Table 11: India Cardiac Pacemaker Market- SWOT Analysis
Table 12: Guidelines for the Import and Manufacture of Medical Devices in India
Table 13: India Cardiac Pacemaker Imports Segmentation from Major Countries in INR Million, FY’2009-FY’2014
Table 14: India Cardiac Imports Segmentation from Major Countries in Thousand Kilograms, FY’2009-FY’2014
Table 15: India Cardiac Pacemaker Exports by Major Countries in INR Million, FY’2009-FY’2014
Table 16: India Cardiac Pacemaker Exports by Major Countries in Thousand Kilograms, FY’2009-FY’2014
Table 17: Competitive Landscape of Major Players in India Cardiac Pacemaker Market
Table 18: St Jude Medical Financials, 2011-2013
Table 19: St Jude Medical Financials by Geography, 2011-2014
Table 20: Total Cardiac Rhythm Management Sales Segmentation by Boston Scientific in USD Million, CY’2009-CY’2014
Table 21: Global Research and Development Expenses of Boston Scientific Limited in USD Million, CY’2009-CY’2014
Table 22: Global Segmentation of Total Cardiac Rhythm Management Sales in Percentage (%), CY’2009-CY2014
Table 23: Cardiac Pacemaker Product Portfolio of Boston Scientific Pvt. Ltd.
Table 24: Global Research and Development Expenses of Medtronic Limited in USD Million, 2009-2014
Table 25: Medtronic Global Revenues from Cardiac Rhythm Disease Management in USD Million, 2009-2014
Table 26: Cardiac Pacemaker Product Profile of Medtronic Limited
Table 27: Global Research and Development Expenses of St Jude Private Limited in USD Million, CY’2009-CY’2014
Table 28: St Jude Medical Private Ltd Total Revenue Segmentation by Geography in Percentage (%), CY’2009-CY’2014
Table 29: Cardiac Pacemaker Product Profile of St Jude Medical Pvt. Ltd.
Table 30: Cardiac Pacemaker Product Profile for MediVed Innovation Pvt Ltd
Table 31: China Cardiac Pacemaker Market Segmentation by Implantability in Percentage (%) and USD Million, 2014
Table 32: China Cardiac Pacemaker Market Segmentation by Number of Chambers in Percentage (%) and USD Million, 2014
Table 33: China Cardiac Pacemaker Market Segmentation by Number of Arial Sensitivity in Percentage (%) and USD Million, 2014
Table 34: China Cardiac Pacemaker Market-SWOT Analysis
Table 35: Competitive Landscape of Major Players in China’s Cardiac Pacemaker Market
Table 36: Medtronic Major Performing Pacemaker Products
Table 37: Biotronik Major Performing Pacemaker Products
Table 38: St. Jude Medical Major Performing Pacemaker Products
Table 39: Shaanxi Qinming Medical Instruments Major Pacemaker Products
Table 40: Japan Cardiac Pacemaker Market Segmentation by Implantability in Percentage (%) and USD Million, 2014
Table 41: Japan Cardiac Pacemaker Market Segmentation by Number of Chambers in Percentage (%) and USD Million, 2014
Table 42: Japan Cardiac Pacemaker Market Segmentation by Specification in Percentage (%) and USD Million, 2014
Table 43: SWOT Analysis of Japan Cardiac Pacemaker Market
Table 44: Competitive Landscape of Domestic Players in Japan Cardiac Pacemaker Market
Table 45: Fukuda Denshi Co Ltd Financial Performance in USD Million, FY’2009-FY’2014
Table 46: Japan Lifeline Co. Ltd Financial Performance in USD Million, FY’2010-FY’2014
Table 47: Competitive Landscape of Global Players in Japan Cardiac Pacemaker Market
Table 48: Net Revenue of Boston Scientific from Japan in USD Million, FY’2009-FY’2014
Table 49: Boston Scientific Pacemaker Portfolio
Table 50: St Jude Medical Net Revenue from Japan in USD Million, FY’2009-FY’2014
Table 51: St Jude Medical Pacemaker Portfolio
Table 52: Biotronik Pacemaker Portfolio
Table 53: South Korea’s Medical Device Classification and Approval Process
Table 54: SWOT Analysis of South Korea Cardiac Pacemaker Market
Table 55: Cause and Effect Relationship between the Macro-Economic and Industry Factors and Asia-Pacific Cardiac Pacemaker Market Future Prospects
Table 56: Asia Pacific cardiac Pacemaker Market Future Projections Segmentation on the Basis of Geography in USD Million, 2015-2019
Table 57: Population above 65 years in Million, 2009-2014
Table 58: Correlation Matrix of the India Cardiac Pacemaker Market
Table 59: Regression Coefficients Output

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022